The results obtained highlighted the presence of a picture where CD38-mediated signals enhance migration of CLL cells and on the contrary, R406 treatment significantly reduced CLL cell migration towards CXCL12 (Fig 3A, n = 10, p<0.05 and p<0.01). This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.